Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganaxolone crossover trial in children with fragile X syndrome
2014-000251-89Phase 2Completed
- Sponsor
- Antwerp University Hospital
- Start
- Aug 2014
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of ganaxolone in Fragile X syndrome (FXS) (2 arms), sponsored by Antwerp University Hospital. Primary endpoint: Clinical Global Impression Improvement scale. Started Aug 2014; status: completed.
02
Drugs
ganaxolone
03
Conditions
Fragile X syndrome (FXS)
Beyond the preview
Go deeper on 2014-000251-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000251-89.